Efficacy and safety of repaglinide, Glurenorm [gliquidone] and Glucobay [acarbose] in Chinese subjects with type 2 diabetes mellitus
Phase of Trial: Phase IV
Latest Information Update: 22 Feb 2017
At a glance
- Drugs Acarbose; Gliquidone; Repaglinide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 06 May 2009 Actual patient number (131) added as reported by ClinicalTrials.gov.
- 06 May 2009 Actual end date (Sep 2004) added as reported by ClinicalTrials.gov.